Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS)
- Supplementary File 1:
ZIP-Document (ZIP, 236 KiB)
Mödinger, Y.; Knaub, K.; Dharsono, T.; Wacker, R.; Meyrat, R.; Land, M.H.; Petraglia, A.L.; Schön, C. Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS). Molecules 2022, 27, 2860. https://doi.org/10.3390/molecules27092860
Mödinger Y, Knaub K, Dharsono T, Wacker R, Meyrat R, Land MH, Petraglia AL, Schön C. Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS). Molecules. 2022; 27(9):2860. https://doi.org/10.3390/molecules27092860
Chicago/Turabian StyleMödinger, Yvonne, Katharina Knaub, Tanita Dharsono, Roland Wacker, Remo Meyrat, M. Hunter Land, Anthony L. Petraglia, and Christiane Schön. 2022. "Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS)" Molecules 27, no. 9: 2860. https://doi.org/10.3390/molecules27092860